Russia currently reports an pharmaceuticals, medicinal chemicals, seasonally adjusted index of 264.3, which represents an increase of 12.3 (4.9%) from 2023 Q4.
Pharmaceuticals, medicinal chemicals, seasonally adjusted index in Russia
No matching regions
Data availability:
Regions:
82
Date range: 2005 Q1 to 2024 Q1
Points:
5,455
Measure:
Index
Similar regions to Russia
Pharmaceuticals, medicinal chemicals
More indicators for Russia
Russia Pharmaceuticals, medicinal chemicals between 2005 Q1 and 2024 Q1
| Period | Pharmaceuticals, medicinal chemicals | Change |
|---|---|---|
| 2024 Q1 | 264.3 | +12.3 |
| 2023 Q4 | 252.0 | +2.6 |
| 2023 Q3 | 249.4 | +4.7 |
| 2023 Q2 | 244.7 | +3.8 |
| 2023 Q1 | 240.9 | +8.9 |
| 2022 Q4 | 232.0 | -9.9 |
| 2022 Q3 | 241.9 | -6.7 |
| 2022 Q2 | 248.6 | -1.2 |
| 2022 Q1 | 249.8 | +6.3 |
| 2021 Q4 | 243.5 | +17.4 |
| 2021 Q3 | 226.1 | +8.0 |
| 2021 Q2 | 218.1 | +1.7 |
| 2021 Q1 | 216.4 | +12.6 |
| 2020 Q4 | 203.8 | +5.4 |
| 2020 Q3 | 198.4 | +9.8 |
| 2020 Q2 | 188.6 | +15.4 |
| 2020 Q1 | 173.2 | +5.2 |
| 2019 Q4 | 168.0 | +7.7 |
| 2019 Q3 | 160.3 | +7.3 |
| 2019 Q2 | 153.0 | +6.2 |
| 2019 Q1 | 146.8 | +10.6 |
| 2018 Q4 | 136.2 | +3.8 |
| 2018 Q3 | 132.4 | +13.1 |
| 2018 Q2 | 119.3 | -8.4 |
| 2018 Q1 | 127.7 | +1.3 |
| 2017 Q4 | 126.4 | +0.1 |
| 2017 Q3 | 126.3 | +2.6 |
| 2017 Q2 | 123.7 | -0.1 |
| 2017 Q1 | 123.8 | +6.1 |
| 2016 Q4 | 117.7 | +3.7 |
| 2016 Q3 | 114.0 | -0.6 |
| 2016 Q2 | 114.6 | +7.6 |
| 2016 Q1 | 107.0 | +4.6 |
| 2015 Q4 | 102.4 | -1.4 |
| 2015 Q3 | 103.8 | +6.0 |
| 2015 Q2 | 97.8 | +1.8 |
| 2015 Q1 | 96.0 | +2.8 |
| 2014 Q4 | 93.2 | +3.5 |
| 2014 Q3 | 89.7 | -1.3 |
| 2014 Q2 | 91.0 | +0.2 |
| 2014 Q1 | 90.8 | -2.3 |
| 2013 Q4 | 93.1 | +0.1 |
| 2013 Q3 | 93.0 | +1.5 |
| 2013 Q2 | 91.5 | +1.0 |
| 2013 Q1 | 90.5 | +1.3 |
| 2012 Q4 | 89.2 | +0.2 |
| 2012 Q3 | 89.0 | +0.8 |
| 2012 Q2 | 88.2 | +1.2 |
| 2012 Q1 | 87.0 | +0.3 |
| 2011 Q4 | 86.7 | +1.4 |
| 2011 Q3 | 85.3 | +1.4 |
| 2011 Q2 | 83.9 | +1.4 |
| 2011 Q1 | 82.5 | +2.2 |
| 2010 Q4 | 80.3 | +1.6 |
| 2010 Q3 | 78.7 | +1.4 |
| 2010 Q2 | 77.3 | +1.4 |
| 2010 Q1 | 75.9 | +1.4 |
| 2009 Q4 | 74.5 | +1.8 |
| 2009 Q3 | 72.7 | +2.7 |
| 2009 Q2 | 70.0 | +5.5 |
| 2009 Q1 | 64.5 | +3.1 |
| 2008 Q4 | 61.4 | -14.9 |
| 2008 Q3 | 76.3 | -1.7 |
| 2008 Q2 | 78.0 | -0.8 |
| 2008 Q1 | 78.8 | -0.1 |
| 2007 Q4 | 78.9 | +0.6 |
| 2007 Q3 | 78.3 | +0.9 |
| 2007 Q2 | 77.4 | +1.0 |
| 2007 Q1 | 76.4 | +1.2 |
| 2006 Q4 | 75.2 | +1.4 |
| 2006 Q3 | 73.8 | +1.2 |
| 2006 Q2 | 72.6 | +1.4 |
| 2006 Q1 | 71.2 | +0.5 |
| 2005 Q4 | 70.7 | +0.7 |
| 2005 Q3 | 70.0 | +0.7 |
| 2005 Q2 | 69.3 | +0.7 |
| 2005 Q1 | 68.6 |